A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease

Brain

Volumn 131, Issue 10, 2008, Pages 2720-2728

  Voon, Valerie ^a,b   Krack, Paul ^c   Lang, Anthony E ^b   Lozano, Andres M ^b   Dujardin, Kathy ^d   Schüpbach, Michael ^e   D'Ambrosia, James ^a   Thobois, Stephane ^f   Tamma, Filippo ^g   Herzog, Jan ^h   Speelman, Johannes D ⁱ   Samanta, Johan ^j   Kubu, Cynthia ^k   Rossignol, Helene ^c   Poon, Yu Yan ^b   Saint Cyr, Jean A ^b   Ardouin, Claire ^c   Moro, Elena ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIV GRENOBLE ALPES   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e INSERM   (France)

^f UNIVERSITÉ LYON 1   (France)

^g Medical School   (Italy)

^h UNIVERSITY OF KIEL   (Germany)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF ARIZONA   (United States)

^k LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

Deep brain stimulation; Depression; Parkinson's disease; Subthalamic stimulation; Suicide

Indexed keywords

AGED; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; SUICIDE; SUICIDE ATTEMPT;

EID: 54949151575     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn214     Document Type: Article

References (32)

1. Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006; 21: 1941-6.
2. Burkhard PR, Vingerhoets FJ, Berney A, Bogousslavsky J, Villemure JG, Ghika J. Suicide after successful deep brain stimulation for movement disorders. Neurology 2004; 63: 2170-2.
3. Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry 2005; 76: 775-9.
4. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Shafer H, Botzel K, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-8.
5. Fahn S, Elton RL. members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease, Vol. 2. Florham Park, NY: Macmillan Healthcare Information; 1987. p. 153-63.
6. Foncke EM, Schuurman PR, Speelman JD. Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology 2006; 66: 142-3.
7. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318: 1309-12.
8. Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery 2005; 56: 1313-21.
9. Hariz G, Hariz MI. Gender distribution in surgery for Parkinson disease. Parkinsonism Relat Disord 2000; 6: 155-7.
10. Hershey T, Revilla FJ, Wernle A, Gibson PS, Dowling JL, Perlmutter JS. Stimulation of STN impairs aspects of cognitive control in PD. Neurology 2004; 62: 1110-4.
11. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002; 287: 455-63.
12. Houeto JL, Mesnage V, Mallet L, Pillon B, Gargiulo M, du Moncel ST, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72: 701-7.
13. Juurlink DN, Herrmann N, Szalai JP, Kopp A, Redelmeier DA. Medical illness and the risk of suicide in the elderly. Arch Intern Med 2004; 164: 1179-84.
14. Keilp JG, Sackeim HA, Brodsky BS, Oquendo MA, Malone KM, Mann JJ. Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 2001; 158: 735-41.
15. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 1999; 56: 617-26.
16. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, et al. Deep brain stimulation: preoperative issues. Mov Disord, 2006; 21 (Suppl 14): S171-96.
17. Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry 2000; 15: 644-9.
18. Maris RW. Suicide. Lancet 2002; 360: 319-26.
19. Myslobodsky M, Lalonde FM, Hicks L. Are patients with Parkinson's disease suicidal? J Geriatr Psychiatry Neurol 2001; 14: 120-4.
20. Oquendo MA, Currier D, Mann JJ. Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors? Acta Psychiatr Scand 2006; 114: 151-8.
21. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 2003; 60: 14-22.
22. Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer disease. Neurology 1986; 36: 1179-85.
23. Pompili M, Girardi P, Ruberto A, Tatarelli R. Suicide in the epilepsies: a meta-analytic investigation of 29 cohorts. Epilepsy Behav 2005; 7: 305-10.
24. Pompili M, Girardi P, Tatarelli G, Angeletti G, Tatarelli R. Suicide after surgical treatment in patients with epilepsy: a meta-analytic investigation. Psychol Rep 2006; 98: 323-38.
25. Schupbach M, Gargiulo M, Welter ML, Mallet L, Behar C, Houeto JL, et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology 2006; 66: 1811-6.
26. Smeding HM, Goudriaan AE, Foncke EM, Schuurman PR, Speelman JD, Schmand B. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry 2007; 78: 517-9.
27. Soulas T, Gurruchaga JM, Palfi S, Cesaro P, Nguyen JP, Fenelon G. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson disease. J Neurology Neurosurg Psychiatry 2008 [Epub ahead of print].
28. Troster AI, Fields JA, Wilkinson S, Pahwa R, Koller WC, Lyons KE. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg 2003; 80: 43-7.
29. van den Wildenberg WP, van Boxtel GJ, van der Molen MW, Bosch DA, Speelman JD, Brunia CH. Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease. J Cogn Neurosci 2006; 18: 626-36.
30. Visser M, Leentjens AF, Marinus J, Stiggelbout AM, van Hilten JJ. Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord 2006; 2: 668-72.
31. Voon V, Kubu C, Krack P, Houeto JL, Troster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21 (Suppl 14): S305-27.
32. World Health Organization: Mental Health: Suicide Prevention and Special Programmes: World Health Organization, 2006. http://www.who.int/mental_health/ prevention/suicide/suicideprevent/en/index.html (12 October 2006, last date accessed).